The rationale behind all the winners for the best capital market deals across Asia Pacific.

Read on to find out the winners of our Deal Awards – Asia Pacific.

Li's practice at the international law firm will focus on fund formation and digital assets, across hedge funds, private equity, real estate and cryptocurrency.

The Chinese vehicle chip firm made its debut on the HKEX amid market instability, and saw a slump in its share price.

Read on to find out the winners of our Deal Awards – Asia.

Pundits have been calling Hong Kong's demise for decades, but with the rush of Chinese listings bringing in fresh liquidity, is it too soon to call time on the city as a financial hub?

Listing against the backdrop of social unrest in Hong Kong, China’s largest infant milk formula maker stays cautious with pricing and leaves something on the table for prospective investors.

Speciality pharmaceutical company CF PharmTech is looking to raise at least $72 million in funding and has its sights set on an IPO in the near future.

Neither debt challenges nor international criticism dampened investor enthusiasm for Power Construction Corporation of China's 3-year and perpetual paper.

FinanceAsia takes a look at what the world’s biggest unicorn has acquired over the years.